Imaging Heart Failure: Current and Future Applications

Canadian Journal of Cardiology

Volumn 29, Issue 3, 2013, Pages 317-328

  Paterson, Ian ^a   Mielniczuk, Lisa M ^b   O'Meara, Eileen ^c   So, Aaron ^d   White, James A ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; GADOLINIUM;

ANGIOCARDIOGRAPHY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HEART; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MOLECULAR IMAGING; NUCLEAR MEDICINE; OUTCOME ASSESSMENT; PERFORMANCE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RELIABILITY; REVIEW; RISK ASSESSMENT; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC TONE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE;

CARDIAC IMAGING TECHNIQUES; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84874301506     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.01.006     Document Type: Review

References (105)

1. Heidenreich P.A., Trogdon J.G., Khavjou O.A., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123:933-944.
2. Ross H., Howlett J., Arnold J.M., et al. Treating the right patient at the right time: access to heart failure care. Can J Cardiol 2006, 22:749-754.
3. Roger V.L., Weston S.A., Redfield M.M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004, 292:344-350.
4. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006, 22:23-45.
5. Lindenfeld J., Albert N.M., Boehmer J.P., et al. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010, 16:e1-194.
6. Malcom J., Arnold O., Howlett J.G., et al. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure-2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol 2008, 24:21-40.
7. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
8. Mele D., Campana M., Sclavo M., et al. Impact of tissue harmonic imaging in patients with distorted left ventricles: improvement in accuracy and reproducibility of visual, manual and automated echocardiographic assessment of left ventricular ejection fraction. Eur J Echocardiogr 2003, 4:59-67.
9. Hare J.L., Brown J.K., Marwick T.H. Performance of conventional echocardiographic parameters and myocardial measurements in the sequential evaluation of left ventricular function. Am J Cardiol 2008, 101:706-711.
10. Jenkins C., Moir S., Chan J., Rakhit D., Haluska B., Marwick T.H. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging. Eur Heart J 2009, 30:98-106.
11. Mulvagh S.L., Rakowski H., Vannan M.A., et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 2008, 21:1179-1201.
12. Douglas P.S., Garcia M.J., Haines D.E., et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 2011, 57:1126-1166.
13. Nayyar S., Magalski A., Khumri T.M., et al. Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction in patients with left ventricular dysfunction and good baseline endocardial border delineation. Am J Cardiol 2006, 98:1110-1114.
14. Dorosz J.L., Lezotte D.C., Weitzenkamp D.A., Allen L.A., Salcedo E.E. Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol 2012, 59:1799-1808.
15. Paulus W.J., Tschope C., Sanderson J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28:2539-2550.
16. Liang H.Y., Cauduro S.A., Pellikka P.A., et al. Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events. Am J Cardiol 2006, 97:866-871.
17. Doughty R.N., Gamble G.D., Poppe K.K., et al. Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail 2008, 10:786-792.
18. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., Quinones M.A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997, 30:1527-1533.
19. Mullens W., Borowski A.G., Curtin R.J., Thomas J.D., Tang W.H. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation 2009, 119:62-70.
20. Dokainish H., Nguyen J.S., Bobek J., Goswami R., Lakkis N.M. Assessment of the American Society of Echocardiography-European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study. Eur J Echocardiogr 2011, 12:857-864.
21. Goyal A., Norton C.R., Thomas T.N., et al. Predictors of incident heart failure in a large insured population: a one million person-year follow-up study. Circ Heart Fail 2010, 3:698-705.
22. Stein G.Y., Kremer A., Shochat T., et al. The diversity of heart failure in a hospitalized population: the role of age. J Card Fail 2012, 18:645-653.
23. Deja M.A., Grayburn P.A., Sun B., et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012, 125:2639-2648.
24. Tribouilloy C., Levy F., Rusinaru D., et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009, 53:1865-1873.
25. Gorcsan J., Tanaka H. Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 2011, 58:1401-1413.
26. Afridi I., Kleiman N.S., Raizner A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995, 91:663-670.
27. Elhendy A., Sozzi F., van Domburg R.T., et al. Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy. Am J Cardiol 2005, 96:469-473.
28. Bonow R.O., Maurer G., Lee K.L., et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011, 364:1617-1625.
29. Bertini M., Ng A.C., Antoni M.L., et al. Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy. Circ Cardiovasc Imaging 2012, 5:383-391.
30. Cullen M.W., Pellikka P.A. Recent advances in stress echocardiography. Curr Opin Cardiol 2011, 26:379-384.
31. Hare J.L., Brown J.K., Leano R., Jenkins C., Woodward N., Marwick T.H. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 2009, 158:294-301.
32. Khoo N.S., Smallhorn J.F., Atallah J., Kaneko S., Mackie A.S., Paterson I. Altered left ventricular tissue velocities, deformation and twist in children and young adults with acute myocarditis and normal ejection fraction. J Am Soc Echocardiogr 2012, 25:294-303.
33. Kato T.S., Noda A., Izawa H., et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 2004, 110:3808-3814.
34. Koyama J., Falk R.H. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 2010, 3:333-342.
35. Prakasa K.R., Wang J., Tandri H., et al. Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol 2007, 100:507-512.
36. Yip G.W., Zhang Q., Xie J.M., et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart 2011, 97:287-294.
37. Dokainish H., Sengupta R., Pillai M., Bobek J., Lakkis N. Assessment of left ventricular systolic function using echocardiography in patients with preserved ejection fraction and elevated diastolic pressures. Am J Cardiol 2008, 101:1766-1771.
38. Nahum J., Bensaid A., Dussault C., et al. Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Cardiovasc Imaging 2010, 3:249-256.
39. McAlister F.A., Ezekowitz J., Hooton N., et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007, 297:2502-2514.
40. Auricchio A., Prinzen F.W. Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J 2011, 75:521-527.
41. Chung E.S., Leon A.R., Tavazzi L., et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008, 117:2608-2616.
42. Norisada K., Kawai H., Tanaka H., et al. Myocardial contractile function in the region of the left ventricular pacing lead predicts the response to cardiac resynchronization therapy assessed by two-dimensional speckle tracking echocardiography. J Am Soc Echocardiogr 2010, 23:181-189.
43. Tanaka H., Hara H., Saba S., Gorcsan J. Usefulness of three-dimensional speckle tracking strain to quantify dyssynchrony and the site of latest mechanical activation. Am J Cardiol 2010, 105:235-242.
44. Ciampi Q., Pratali L., Citro R., Piacenti M., Villari B., Picano E. Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography. Eur J Heart Fail 2009, 11:489-496.
45. Gasparini M., Muto C., Iacopino S., et al. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw Dose DObutamine Stress-Echo Test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study. Am Heart J 2012, 163:422-429.
46. Hendel R.C., Berman D.S., Di Carli M.F., et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Circulation 2009, 119:e561-e587.
47. Kim C., Kwok Y.S., Heagerty P., Redberg R. Pharmacologic stress testing for coronary disease diagnosis: a meta-analysis. Am Heart J 2001, 142:934-944.
48. Underwood S.R., Anagnostopoulos C., Cerqueira M., et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004, 31:261-291.
49. Nakata T., Hashimoto A., Wakabayashi T., Kusuoka H., Nishimura T. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database. JACC Cardiovasc Imaging 2009, 2:1393-1400.
50. Candell-Riera J., Romero-Farina G., Aguade-Bruix S., Castell-Conesa J., de Leon G., Garcia-Dorado D. Prognostic value of myocardial perfusion-gated SPECT in patients with ischemic cardiomyopathy. J Nucl Cardiol 2009, 16:212-221.
51. Di Carli M.F., Dorbala S., Meserve J., El Fakhri G., Sitek A., Moore S.C. Clinical myocardial perfusion PET/CT. J Nucl Med 2007, 48:783-793.
52. Beanlands R.S., Chow B.J., Dick A., et al. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease-executive summary. Can J Cardiol 2007, 23:107-119.
53. Senthamizhchelvan S., Bravo P.E., Esaias C., et al. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med 2010, 51:1592-1599.
54. Tio R.A., Dabeshlim A., Siebelink H.M., et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009, 50:214-219.
55. Bax J.J., Wijns W., Cornel J.H., Visser F.C., Boersma E., Fioretti P.M. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease. comparison of pooled data. J Am Coll Cardiol 1997, 30:1451-1460.
56. Partington S.L., Kwong R.Y., Dorbala S. Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev 2011, 16:381-395.
57. Schinkel A.F., Bax J.J., Poldermans D., Elhendy A., Ferrari R., Rahimtoola S.H. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007, 32:375-410.
58. Abraham A., Nichol G., Williams K.A., et al. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med 2010, 51:567-574.
59. Langer O., Halldin C. PET and SPET tracers for mapping the cardiac nervous system. Eur J Nucl Med Mol Imaging 2002, 29:416-434.
60. Bengel F.M., Higuchi T., Javadi M.S., Lautamaki R. Cardiac positron emission tomography. J Am Coll Cardiol 2009, 54:1-15.
61. Jacobson A.F., Senior R., Cerqueira M.D., et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010, 55:2212-2221.
62. Boogers M.J., Fukushima K., Bengel F.M., Bax J.J. The role of nuclear imaging in the failing heart: myocardial blood flow, sympathetic innervation, and future applications. Heart Fail Rev 2011, 16:411-423.
63. Chen I.Y., Wu J.C. Cardiovascular molecular imaging: focus on clinical translation. Circulation 2011, 123:425-443.
64. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17:545-580.
65. Cherry S.R. Multimodality imaging: beyond PET/CT and SPECT/CT. Semin Nucl Med 2009, 39:348-353.
66. Judenhofer M.S., Wehrl H.F., Newport D.F., et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008, 14:459-465.
67. Laitinen I., Saraste A., Weidl E., et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging 2009, 2:331-338.
68. Strohm O., Schulz-Menger J., Pilz B., Osterziel K.J., Dietz R., Friedrich M.G. Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001, 13:367-371.
69. Mooij C.F., de Wit C.J., Graham D.A., Powell A.J., Geva T. Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging 2008, 28:67-73.
70. Cawley P.J., Maki J.H., Otto C.M. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation 2009, 119:468-478.
71. Assomull R.G., Shakespeare C., Kalra P.R., et al. Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011, 124:1351-1360.
72. Greenwood J.P., Maredia N., Younger J.F., et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012, 379:453-460.
73. Bruder O., Schneider S., Nothnagel D., et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009, 54:1457-1466.
74. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445-1453.
75. Selvanayagam J.B., Kardos A., Francis J.M., et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004, 110:1535-1541.
76. Gerber B.L., Rousseau M.F., Ahn S.A., et al. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy. J Am Coll Cardiol 2012, 59:825-835.
77. Hendel R.C., Patel M.R., Kramer C.M., et al. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 2006, 48:1475-1497.
78. Bleeker G.B., Kaandorp T.A., Lamb H.J., et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006, 113:969-976.
79. White J.A., Yee R., Yuan X., et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006, 48:1953-1960.
80. Leyva F., Foley P.W., Chalil S., et al. Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011, 13:29.
81. Gao P., Yee R., Gula L., et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012, 5:448-456.
82. Ugander M., Oki A.J., Hsu L.Y., et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012, 33:1268-1278.
83. Martin E.T., Coman J.A., Shellock F.G., Pulling C.C., Fair R., Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004, 43:1315-1324.
84. Junttila M.J., Fishman J.E., Lopera G.A., et al. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart 2011, 97:1852-1856.
85. Naehle C.P., Kreuz J., Strach K., et al. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J 2011, 161:1096-1105.
86. Wu Y.W., Tadamura E., Yamamuro M., et al. Estimation of global and regional cardiac function using 64-slice computed tomography: a comparison study with echocardiography, gated-SPECT and cardiovascular magnetic resonance. Int J Cardiol 2008, 128:69-76.
87. Nakazato R., Tamarappoo B.K., Smith T.W., et al. Assessment of left ventricular regional wall motion and ejection fraction with low-radiation dose helical dual-source CT: comparison to two-dimensional echocardiography. J Cardiovasc Comput Tomogr 2011, 5:149-157.
88. Schroeder J., Peterschroeder A., Vaske B., et al. Cardiac volumetry in patients with heart failure and reduced ejection fraction: a comparative study correlating multi-slice computed tomography and magnetic resonance tomography. Reasons for intermodal disagreement. Clin Res Cardiol 2009, 98:739-747.
89. Burianova L., Riedlbauchova L., Lefflerova K., et al. Assessment of left ventricular function in non-dilated and dilated hearts: comparison of contrast-enhanced 2-dimensional echocardiography with multi-detector row CT angiography. Acta Cardiol 2009, 64:787-794.
90. Maffei E., Palumbo A., Martini C., et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography in a large population of patients without revascularisation: registry data and review of multicentre trials. Radiol Med 2010, 115:368-384.
91. Ghostine S., Caussin C., Habis M., et al. Non-invasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J 2008, 29:2133-2140.
92. Kim H.J., Vignon-Clementel I.E., Coogan J.S., Figueroa C.A., Jansen K.E., Taylor C.A. Patient-specific modeling of blood flow and pressure in human coronary arteries. Ann Biomed Eng 2010, 38:3195-3209.
93. Koo B.K., Erglis A., Doh J.H., et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol 2011, 58:1989-1997.
94. Min J.K., Leipsic J., Pencina M.J., et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 2012, 308:1237-1245.
95. So A., Wisenberg G., Islam A., et al. Non-invasive assessment of functionally relevant coronary artery stenoses with quantitative CT perfusion: preliminary clinical experiences. Eur Radiol 2012, 22:39-50.
96. Bamberg F., Becker A., Schwarz F., et al. Detection of hemodynamically significant coronary artery stenosis: incremental diagnostic value of dynamic CT-based myocardial perfusion imaging. Radiology 2011, 260:689-698.
97. Habis M., Capderou A., Ghostine S., et al. Acute myocardial infarction early viability assessment by 64-slice computed tomography immediately after coronary angiography: comparison with low-dose dobutamine echocardiography. J Am Coll Cardiol 2007, 49:1178-1185.
98. Chiou K.R., Liu C.P., Peng N.J., et al. Identification and viability assessment of infarcted myocardium with late enhancement multidetector computed tomography: comparison with thallium single photon emission computed tomography and echocardiography. Am Heart J 2008, 155:738-745.
99. Bauer R.W., Kerl J.M., Fischer N., et al. Dual-energy CT for the assessment of chronic myocardial infarction in patients with chronic coronary artery disease: comparison with 3-T MRI. AJR Am J Roentgenol 2010, 195:639-646.
100. Fink C., Krissak R., Henzler T., et al. Radiation dose at coronary CT angiography: second-generation dual-source CT versus single-source 64-MDCT and first-generation dual-source CT. AJR Am J Roentgenol 2011, 196:W550-W557.
101. Nyman U., Almen T., Jacobsson B., Aspelin P. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?. Eur Radiol 2012, 22:1366-1371.
102. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
103. Franssen C., Paulus W.J. The future diagnosis of heart failure with normal ejection fraction: less imaging, more biomarkers?. Eur J Heart Fail 2011, 13:1043-1045.
104. Tricoci P., Allen J.M., Kramer J.M., Califf R.M., Smith S.C. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009, 301:831-841.
105. Shaw L.J., Narula J. Cardiovascular imaging quality-more than a pretty picture!. JACC Cardiovasc Imaging 2008, 1:266-269.